Unresectable Extrahepatic Bile Duct Carcinoma

6 clinical trials · Condition

Record	Firm	Date
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers (NCT03768414)	SWOG Cancer Research Network	2019-02-07
Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma (NCT02856568)	Mayo Clinic	2017-05-01
Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers (NCT02392637)	M.D. Anderson Cancer Center	2015-04-02
Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery (NCT02042443)	National Cancer Institute (NCI)	2014-02-01
MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery (NCT01425879)	National Cancer Institute (NCI)	2011-04-01
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma (NCT01093222)	National Cancer Institute (NCI)	2010-04-01

Every clearance here is in the API, with alerts when new ones post.